These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32683306)

  • 1. COVID-19 in MS and NMOSD: A multicentric online national survey in Chile.
    Ciampi E; Uribe-San-Martín R; Soler B; Fernández R; García P; Navarrete-Asenjo C; Tirapegui JM; Torres R; Polanco J; Suárez F; Cuello MJ; Cárcamo C
    Mult Scler Relat Disord; 2020 Oct; 45():102392. PubMed ID: 32683306
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile.
    Ciampi E; Uribe-San-Martin R; Cárcamo C
    Mult Scler Relat Disord; 2020 Jul; 42():102204. PubMed ID: 32570203
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders.
    Fan M; Qiu W; Bu B; Xu Y; Yang H; Huang D; Lau AY; Guo J; Zhang MN; Zhang X; Yang CS; Chen J; Zheng P; Liu Q; Zhang C; Shi FD
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32503092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic: a practical approach.
    ApÓstolos-Pereira SL; Silva GD; Disserol CCD; Feo LB; Matos AMB; Schoeps VA; Gomes ABAGR; Boaventura M; Mendes MF; Callegaro D
    Arq Neuropsiquiatr; 2020 Jul; 78(7):430-439. PubMed ID: 32609290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of COVID-19 on patients with neuromyelitis optica spectrum disorder; a pilot study.
    Tomczak A; Han MH
    Mult Scler Relat Disord; 2020 Oct; 45():102347. PubMed ID: 32645636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Salama S; Giovannoni G; Hawkes CH; Lechner-Scott J; Waubant E; Levy M
    Mult Scler Relat Disord; 2020 Jul; 42():102259. PubMed ID: 32571580
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening neuromyelitis optica patients for COVID-19 infection.
    Mirmosayyeb O; Vaheb S; Barzegar M; Shaygannejad V; Bonavita S; Ghajarzadeh M
    Autoimmun Rev; 2020 Nov; 19(11):102669. PubMed ID: 32942032
    [No Abstract]   [Full Text] [Related]  

  • 8. The COVID-19 pandemic and the use of MS disease-modifying therapies.
    Giovannoni G; Hawkes C; Lechner-Scott J; Levy M; Waubant E; Gold J
    Mult Scler Relat Disord; 2020 Apr; 39():102073. PubMed ID: 32334820
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
    Stastna D; Menkyova I; Drahota J; Mazouchova A; Adamkova J; Ampapa R; Grunermelova M; Peterka M; Recmanova E; Rockova P; Rous M; Stetkarova I; Valis M; Vachova M; Woznicova I; Horakova D
    Mult Scler Relat Disord; 2021 Sep; 54():103104. PubMed ID: 34216998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
    Ghajarzadeh M; Bonavita S
    Neurol Sci; 2020 Sep; 41(9):2315-2316. PubMed ID: 32638135
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural History of Asymptomatic SARS-CoV-2 Infection.
    Sakurai A; Sasaki T; Kato S; Hayashi M; Tsuzuki SI; Ishihara T; Iwata M; Morise Z; Doi Y
    N Engl J Med; 2020 Aug; 383(9):885-886. PubMed ID: 32530584
    [No Abstract]   [Full Text] [Related]  

  • 12. Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients.
    Telfer P; De la Fuente J; Sohal M; Brown R; Eleftheriou P; Roy N; Piel FB; Chakravorty S; Gardner K; Velangi M; Drasar E; Shah F; Porter JB; Trompeter S; Atoyebi W; Szydlo R; Anie KA; Ryan K; Sharif J; Wright J; Astwood E; Nicolle CS; Webster A; Roberts DJ; Lugthart S; Kaya B; Awogbade M; Rees DC; Hollingsworth R; Inusa B; Howard J; Layton DM
    Haematologica; 2020 Nov; 105(11):2651-2654. PubMed ID: 33054122
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of COVID-19 on patients with asthma.
    Pignatti P; Visca D; Cherubino F; Zampogna E; Spanevello A
    Int J Tuberc Lung Dis; 2020 Nov; 24(11):1217-1219. PubMed ID: 33172533
    [No Abstract]   [Full Text] [Related]  

  • 14. [Concepts for good decision-making in the COVID-19 pandemic in Chile].
    Canals L M
    Rev Chilena Infectol; 2020 Apr; 37(2):170-172. PubMed ID: 32730484
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical characteristics of SARS-CoV-2 infection in a rural area in Germany.
    von Meißner WCG; Strumann C; Kochen MM; Blickle PG; Wölk B; Pömsl J; Fink W; Steinhaeuser J
    Rural Remote Health; 2020 Sep; 20(3):6325. PubMed ID: 32955912
    [No Abstract]   [Full Text] [Related]  

  • 16. Follow-up of asymptomatic patients with SARS-CoV-2 infection.
    Zhou X; Li Y; Li T; Zhang W
    Clin Microbiol Infect; 2020 Jul; 26(7):957-959. PubMed ID: 32234453
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19, impact on myeloma patients.
    Dufour I; Raedemaeker J; Andreozzi F; Verstraete G; Bailly S; Delforge M; Storms P; Jacquy C; Van de Velde A; Mineur P; Lejeune M; Bauwens D; Van Obbergh F; Kentos A; Nguyen J; Fostier K; De Weweire A; Meuleman N; Vekemans MC
    Ann Hematol; 2020 Aug; 99(8):1947-1949. PubMed ID: 32577846
    [No Abstract]   [Full Text] [Related]  

  • 18. Lung Ultrasound Evolution in a Patient with COVID-19.
    Royer O; Couture EJ; Langevin S
    Am J Respir Crit Care Med; 2020 Nov; 202(9):1297-1298. PubMed ID: 32976034
    [No Abstract]   [Full Text] [Related]  

  • 19. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients.
    Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Guo Y; Dai Y; Xu Y; Cai Y; Chen X; Zhang Z; Huang K
    Sci China Life Sci; 2020 Apr; 63(4):606-609. PubMed ID: 32170625
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating patients with multiple sclerosis during the COVID-19 pandemic: Assessing the expert recommendations.
    Guevara C; Villa E; Rosas CS; Diaz V; Naves R
    Mult Scler Relat Disord; 2020 Aug; 43():102224. PubMed ID: 32464582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.